Skye Bioscience to Announce 2025 Financial Results and Business Update on March 10, 2026 [Yahoo! Finance]
Skye Bioscience to Announce 2025 Financial Results and Business Update on March 10, 2026
Skye Reports Positive CBeyond Phase 2a Extension Interim Study Results for Nimacimab in Combination With Semaglutide [Yahoo! Finance]
Skye Reports Positive CBeyond Phase 2a Extension Interim Study Results for Nimacimab in Combination With Semaglutide
Skye Bioscience Highlights Attributes of its Peripherally-restricted CB1 Inhibitor Antibody at Keystone Obesity Conference